Ocular Therapeutix, Inc.

OCULNASDAQ • USD
ThemeBiotech - Drug Development›Rare Disease Therapeutics
9.85 USD
↗ 0.09 (0.95%)🟢LIVE (AS OF 10:16 AM EDT)
🟢Market: OPEN

OCUL is currently priced at $9.85. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Jun 25, 2026.

Open?$9.78
High?$9.95
Low?$9.69
Prev. Close?$9.76
Volume?179.3K
Avg. Volume?2.9M
VWAP?$9.84
Rel. Volume?0.06x
Bid / Ask
Bid?$9.60 × 500
Ask?$9.96 × 100
Spread?$0.36
Midpoint?$9.78
Valuation & Ratios
Market Cap?2.1B
Shares Out?219.0M
Float?179.1M
Float %?82.3%
P/E Ratio?N/A
P/B Ratio?3.67
EPS?-$1.33
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Themes
Biotech - Drug Development›Rare Disease TherapeuticsMedical Devices & HealthTech›Wearable Medical Devices
Employees
325
Market Cap
2.2B
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.ocutx.com
Listed
2014-07-25
Address
14 CROSBY DRIVE, 3RD FLOOR
BEDFORD, MA 01730
Phone: 781-357-4000
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
100
Momentum?
50
Short Sent.?
23
Piotroski F-Score?3/9Weak
Altman Z-Score?5.99Safe
Confidence?56%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?14.77%High
Short Interest?26.5M
Days to Cover?11.9
Free Float179.1M
Avg Daily Volume2.2M
Settlement Date2026-06-15
Financial Health
Current Ratio?14.81Strong
Quick Ratio?14.73Strong
Cash Ratio?13.98Strong
Debt/Equity?0.12Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
47
3.67FAIR▾
P/S?
Peers
100
S&P
3
41.07HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-5.2CHEAP▾
EV/Sales?
Peers
100
S&P
3
29.64HIGH▾
Returns & Efficiency
ROE?
S&P
3
-50.0%WEAK▾
ROA?
S&P
3
-39.7%WEAK▾
Cash Flow & Enterprise
FCF?$-240944000
Enterprise Value?$1.5B
Fundamentals ratios updated end of day
MarketsMoversWatchlist